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Objectives: The major problems in the development of tracheal prosthesis are
anastomotic dehiscence and stenosis, caused by poor epithelialization of the pros-
thetic graft. We developed a novel tracheal prosthesis with viable mucosa trans-
planted from the oral cavity and reported excellent long-term results after thoracic
tracheal replacements in dogs. In the current study, we used tissue-engineering
techniques to construct a mucosal prosthetic lining from skin cells and evaluated its
usefulness in tracheal replacement.
Methods: Abdominal skin patches (5  10 cm) were harvested from 10 adult
mongrel dogs. The epithelial cells were separated, cultured in vitro for 4 weeks, and
then seeded onto a porous polylactic glycolic acid scaffold (6  8 cm) to construct
a lining mucosa. This was then mounted onto the prosthesis framework, made with
polypropylene mesh reinforced with polypropylene rings. The mucosa-lined pros-
thesis was wrapped with the greater omentum of the same dog and placed in the
peritoneal cavity for 1 week. Complete surgical resection and replacement of a
thoracic tracheal segment (5 cm in length, just above the carina) was then performed
using the prosthesis.
Results: The animals regained full activity and survived with normal activity.
Bronchoscopy at 1 week and at 1 and 2 months revealed no stenosis in the
anastomosis.
Conclusions: This highly biocompatible tracheal prosthesis could prove useful for
the reconstruction of large, circumferential tracheal defects.
The reconstruction of large, circumferential tracheal defects remains achallenging problem in tracheal surgery. Many types of prostheticgrafts and tissue grafts have been used in attempts to repair suchdefects but with limited success because of graft ischemia andimmune rejection leading to anastomotic dehiscence and stenosis.The prosthetic trachea is poorly epithelialized and subject to chronic
infections, which stimulate granular tissue formation, anastomotic disruption, and
erosion of the major blood vessels.1-7
We developed a novel tracheal prosthesis with viable mucosa and reported
excellent long-term results after using it for thoracic tracheal replacements in
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dogs.8,9 The prosthesis has a basic framework made with
high-porous synthetic material to promote ingrowths of new
vessel. The luminal surface is lined with autogenous mucosa
from the oral cavity to promote epithelialization of the graft,
and biodegradable glues such as gelatin are used to enhance
an airtight attachment between tissue and the prosthesis. We
initially transplanted the graft into the greater omentum to
promote vascularization of the graft and to maintain the
viability of the implanted mucosa. We found that after 6
months the prostheses were completely incorporated by the
host trachea in all dogs and confluent epithelialization was
confirmed histologically from the upper to the lower anas-
tomotic site of the prosthesis. Furthermore, the transplanted
mucosal cell types had changed to ciliated columnar epithe-
lium.
In this study, aimed at constructing a readily usable
artificial trachea, we used tissue-engineering techniques to
make a prosthetic lining mucosa from skin epithelium and
evaluated its usefulness for tracheal replacement.
Materials and Methods
Animals
The animals used for this study were 10 adult mongrel dogs,
weighing 15 to 20 kg. The dogs were acclimated for 7 days before
experiments. They were individually housed and maintained at an
environmental temperature of 22°  2°C and on a 12/12-hour
light/dark cycle. They were fed a canine diet (Purina Korea Co,
Seoul, Korea) with water ad libitum. All animals received humane
care in compliance with the “Guide for the Care and Use of
Laboratory Animals” prepared by the Institute of Laboratory An-
imal Resources and published by the National Institutes of Health
and The Animal Experiment Guidelines of Samsung Biomedical
Research Institute. The experiment is summarized in Table 1.
Preparation of the Prosthesis
The construction of the prosthesis has been described previous-
ly.8,9 Ten polypropylene rings (diameter 30 mm; thickness 1 mm;
width 1 mm) were attached at 5-mm intervals to the external
surface of an open-ended cylinder made of polypropylene mesh
(Ethicon, Somerville, NJ), using thermal melt bonding. Type B
bovine gelatin (mean molecular weight 23,000; Sigma, St Louis,
Mo), which does not block the diffusion of oxygen and nutrients
from omental blood vessels, was used to make an adhesive surface
for the oral mucosa and omentum. The prosthesis was air-dried and
then sterilized using ethylene oxide gas (Figure 1).
Preparation of Mucosa from Skin Epithelium by
Tissue Engineering
Porous polymer scaffolds were made from an 85:15 copolymer of
poly (D,L-lactide-co-glycolide) (PLGA; Polysorb; Alkermes, Wil-
mington, Ohio), a white to nearly white powder with an average
molecular weight of 110,000 Da. Scaffolds were prepared using a
particulate-leaching technique. The polymer was dissolved in chlo-
roform (Sigma) to yield a 10% solution, and sieved gelatin parti-
cles (Sigma) were added. The vortexed dispersion was cast in a
Teflon container (5  5 cm) (Daelim, Seoul, Korea), followed by
vacuum drying for 48 hours. Scaffolds were annealed at a temper-
ature of 120°C in a drying oven (Chang Shin Scientific Co, Seoul,
Korea). The scaffold was then immersed in deionized water for 48
hours to leach out any particles and freeze-dried under a vacuum
for 24 hours. All scaffolds were stored under vacuum until used.
Cell Preparations
For cell recovery and culture, adult mongrel dogs weighing 15 to
20 kg were anesthetized with intravenous thiopental sodium
(10-15 mg/kg) and immobilized in a supine position. After injec-
tion of vecuronium bromide (0.1 mg/kg), the dogs were intubated
orally using a cuffed endotracheal tube (inner diameter 6.5 mm)
connected to a respirator (Narkomed model 2B; Dra¨ger North
America, Minster, Ohio). Anesthesia was maintained by inhalation
of a gas mix (O2 1 L/min; N2O 1 L/min; halothane 1%-1.5%). The
operative area was shaved and disinfected. An abdominal skin
patch (5  10 cm) was harvested, cut into small pieces after
removal of the subcutaneous fatty tissues, and washed twice in
phosphate-buffered saline solution (PBS) containing antibiotics.
Tissues were immersed in 0.02% dispase (Gibco-BRL, Life Tech-
nologies, Gaithersburg, Md) solution for 16 hours at 4°C. Dispase
was prepared under sterile conditions 1 day before surgery by
diluting it with sterile PBS to 50 g/0.05 mL (pH  7.4). They
were then treated with 0.1% trypsin solution for 10 minutes at
37°C to separate the cells. Enzyme activity was stopped by adding
Dulbecco’s modified Eagle’s medium (DMEM) containing 10%
fetal bovine serum, and the suspension was filtered to remove
undigested tissue. The suspension was centrifuged for 5 minutes at
TABLE 1. Schematic presentation of animal experiment for
the development of tissue-engineered tracheal prosthesis
Animal
no.
Cx
peritoneum* Cx trachea†
Bronchoscopic evaluation
1 week 1 month 2 month
Dog 1 None None Edema Good Good
Dog 2 None Pneumothorax Edema Hypertrophy Good
Dog 3 None None Edema Good Good
Dog 4 None None Edema Good Good
Dog 5 Eviceration‡ Not done Not
done
Not done Not
done
Dog 6 None Pneumothorax Good Good Good
Dog 7 None None Edema Hypertrophy Good
Dog 8 None None Edema Hypertrophy Good
Dog 9 None None Good Good Good
Dog 10 None None Edema Good Good
The animals were numbered in order of experiment. Every animal with
intrathoracic tracheal replacement survived and will be killed for the
systematic gross and microscopic examination after 6 months of obser-
vation. Bronchoscopic evaluations were performed after intrathoracic
tracheal replacement. Hypertrophy of the anastomosis, especially at the
proximal anastomosis, was noticed in some animals.
*Complication after transplantation of the prosthesis into the peritoneal
cavity for in vivo culture.
†Complication after intrathoracic tracheal replacement.
‡At 5 days after the intraperitoneal placement of the prosthesis, bowel
protrusion through the abdominal wound was noticed. Intrathoracic tra-
cheal replacement was not performed in this animal because of the risk of
graft infection.
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1500 rpm, and the cell pellet was resuspended in full keratinocyte
culture medium (Gibco-BRL).
To plate the scaffolds, cell numbers and viability were quanti-
fied by trypan blue vital dye staining and counted using a hemo-
cytometer and a light microscope (Nikon, Kawasaki, Japan).
PLGA scaffolds (6  8 cm) were prewetted with DMEM and
seeded with 150 L of a suspension of culture medium containing
4  106 cells. Cell-polymer constructs were incubated for a week
in full keratinocyte culture medium containing 1% penicillin-
Figure 2. Bronchoscopic findings of the transplanted prosthesis.
A, One week after surgery, erythematous and edematous change
around the anastomosis were seen. B, One month after surgery,
mild hypertrophy of the proximal anastomosis was observed. C,
Two months after surgery, no stenosis was identified.
Figure 1. A, Tracheal prosthesis made from polypropylene mesh
and polypropylene rings, before (Frame) and after gelatin coating
(Gelatin Coated). B, Tissue-engineered mucosa from skin epithe-
lium on the greater omentum. C, Tracheal prosthesis after 1 week
of implantation. Tissue-engineered mucosa, which lined the inner
surface of the prosthesis, tightly connected to the omental wrap-
ping.
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streptomycin under 5% CO2 at 37°C until implantation into the
peritoneal cavity. The medium was changed every other day.
In Vivo Culture of the Prosthesis
After the preparation of these implants, each animal was anesthe-
tized as described above. The greater omentum was brought out of
the peritoneal cavity via a small midline laparotomy. Each pre-
pared autogenous tracheal prosthesis was wrapped with the lower
portion of the greater omentum, fixed with several interrupted
polypropylene 4-0 sutures, and replaced into the peritoneal cavity.
The wound was sutured and the dog was allowed to recover.
Intrathoracic Tracheal Replacement
One week later, the same method of anesthesia was used to
perform the tracheal implants. A second midline upper abdominal
incision was used to free an adequate length of the greater omen-
tum with its tracheal prosthesis. The left gastroepiploic blood
vessels were ligated, divided at their origin from the splenic
vessels, and dissected from the stomach wall. The omentum with
its prosthesis was passed into the right thorax without torsion or
tension via a 2-cm opening in the dome of the right diaphragm and
the abdomen was then closed.
The trachea was then approached through a right posterolateral
thoracotomy in the fourth intercostal space. After division of the
azygos vein, the distal trachea was exposed. Ten distal tracheal
cartilaginous rings (5 cm) were mobilized and resected from 6 cm
to 1 cm above the carina. Ventilation and anesthesia were main-
tained via a new endotracheal tube passed through a sterile corru-
gated ventilating line. The tracheal prosthesis was raised into the
operation field from the thorax and implanted in the resected
trachea with interrupted 4-0 polyglactin 910 sutures. End-to-end
anastomoses were performed, first distal and then proximal. The
redundant omentum was used for loose wrapping of the proximal
anastomosis.
A 24F drain tube was inserted into the thorax through a sepa-
rate stab incision and the incision was closed. The chest drain was
removed in the operating theater after the lung had been inflated.
Anesthesia was stopped and the endotracheal tube was removed.
Postoperatively, each dog received an intravenous injection of
500 mg cefamezine on the day of the operation and 250 mg of
cefamezine (intramuscular) per day for 3 days.
Postoperative Observations
Bronchoscopy was carried out periodically with the animals under
general anesthesia. The luminal surface was observed with a
bronchoscope (model BF1T240, Olympus Optical Co, Ltd, Tokyo,
Japan) to evaluate the incorporation of each implanted prosthesis
with its host tissue and to check on any complications such as
exposure of the mesh framework or luminal stenosis.
Results
All animals resumed full activity within 12 hours except 2
with pneumothorax: 1 needed a reinsertion of the chest tube
to expand the collapsed right lung, and the other normalized
without any intervention. However, both regained full ac-
tivity within 2 days. One of the initial 10 animals with a
tracheal prosthesis implanted in its peritoneal cavity devel-
oped bowel protrusion through the wound site after 5 days.
This animal was omitted from the experiment because we
suspected graft infection (Table 1).
After 1 week of implantation in the peritoneal cavity
with its omental wrapping, the tissue-engineered mucosa
was well incorporated with the prosthesis and surrounding
omentum, although some areas were still brittle. Connective
tissue had formed on the peripheral bare area where the
mucosa had not formed a complete lining, and this helped to
maintain the air-tightness of the prosthesis.
Bronchoscopic Examination
Fiber optic bronchoscopic examination 1 week after surgery
showed mild erythematous and edematous changes around
the anastomoses. However, these did not obstruct the tra-
cheal lumen and abated after 1 month in every dog. Mild
hypertrophy of the proximal anastomosis was observed in 2
of 9 dogs at 1 month; however, there were no further
changes at 2 months when the transplanted grafts were
almost completely incorporated with the neighboring tra-
cheal tissue (Figure 2). Every animal with intrathoracic
tracheal replacement will be killed for the systematic gross
and microscopic examination after 6 months of observation.
Discussion
Neville and colleagues10 stated that the ideal tracheal pros-
thesis should be airtight, of adequate consistency, and well
tolerated by the host. It should also cause minimal inflam-
matory reactions but still be incorporated by the surround-
ing tissue. Moreover, it should be impervious to fibroblastic
and bacterial invasion of the lumen and yet permit the
ingrowth of respiratory epithelium along the lumen. We
developed a novel tracheal prosthetic graft that may fulfill
these requirements.8,9 The basic framework of the graft is of
highly porous synthetic material that promotes the ingrowth
of new vessels. The luminal surface of the original graft was
lined with autogenous mucosa from the oral cavity to pro-
mote the epithelialization of the graft. A biodegradable glue
such as gelatin was used to enhance the airtight attachment
between tissue and prosthetics. We prepared the graft by
transplanting it into the greater omentum to promote vas-
cularization of the graft and to maintain the viability of the
implanted mucosa. In these studies, we concluded that to
prevent graft rejection, autogenous mucosa is critical in the
development of an artificial trachea.
Initially, we tried to use buccal mucosa because we had
good results from previous experiments. However, because
of the limited size of the oral cavity of the dog and hence a
limited number of cells, the preparation of the mucosa took
too long (typically more than 6 or 7 weeks after the harvest).
We therefore changed the source of epithelial cells from the
buccal mucosa to the skin.
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The use of skin for the source of epithelial cells may be
controversial because it is unclear whether such epithelium
will be suitable for the luminal surface of the airway. We
plan to wait more than 6 months for the systematic histo-
logic evaluation because we had observed that all the lining
epithelium had been replaced with ciliated columnar epithe-
lium as in the normal airway tract, even though originally it
had been stratified squamous epithelium.9
In these experiments, we replaced experimental intratho-
racic tracheal lesions with our prostheses. Contrary to cer-
vical tracheal replacements, where the failure of a prosthesis
would not be life-threatening, intrathoracic tracheal replace-
ment has to be successful to save the patient’s life. Any
complications, such as minor dehiscence of the anastomosis
or stenosis by ingrowth of granulation tissue, may hamper
the activity of the recipient. Therefore, an implanted tra-
cheal prosthesis should maintain its luminal status, diame-
ter, and viability throughout life. In this study, all the dogs
resumed full activity after replacement of the intrathoracic
trachea and showed good tracheal anatomy. No animal
showed anastomotic or central stenosis. We believe that
maintenance of the viability of the cells on the tissue-
engineered mucosa helps prevent the chronic infections that
could lead to the formation of granulation tissues. Previous
report on tracheal prostheses3 have shown that when pros-
theses longer than 5 cm were used there were complications
such as mesh exposure and luminal stenosis. However, no
such complication was noted in our experiments. Moreover,
central stenosis, which is 1 of the most frequent complica-
tions associated with porous types of tracheal prostheses,
was not a problem for our prosthesis.
There are several unanswered questions and drawbacks
yet in this experiment. First of all, although we had good
results in survival and postreplacement function of the
tested animals, we do not know whether the implanted cells
could maintain their viability and proliferative activity.
From the previous experiment, we had observed that the
cells had unaltered cellular morphology, suggestive of nor-
mal cell function.9 We plan to study systematic and serial
gross and microscopic examination from 1 week to 6
months after the replacement. Such a study will help to
know whether the graft was infected, caused inflammatory
reaction to the surrounding tissue, and permitted the in-
growth of respiratory epithelium from the adjacent tracheal
mucosa. Second, an incision is needed to obtain autogenous
material, rather a long waiting time to establish the cell
culture and lengthy placement of the prosthesis in the peri-
toneal cavity. We hope that technical development of tissue
engineering will simplify the process and shorten the pre-
paratory time. Third, literally speaking, this prosthesis is a
hybrid graft undergoing graft regeneration following im-
plantation11 and is not an ultimate tissue-engineered tra-
cheal prosthesis. Sometime in the future, we will have a
tissue-engineered tracheal prosthesis that can be readily
available and simple to use.
However, we successfully performed long-segment tho-
racic tracheal replacement with immediate recovery of the
animals and long-term stenosis-free trachea. These results
also confirm the high biocompatibility of our current pros-
thesis. We conclude that although we need to confirm its
long-term safety and biocompatibility, this tracheal prosthe-
sis with its tissue-engineered skin cell–based mucosa ap-
pears promising for the repair of thoracic tracheal defects.
We gratefully appreciate Mr Kwang Hyun Gil and Young Woo
Kim for their support for the animal care and assistance in animal
experimental surgery.
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Discussion
Dr Paolo Macchiarini (Hannover, Germany). Yesterday I had
a wonderful discussion with Mr Garillo, and he asked me, “Paolo,
do you know why I wrote these 2 editorials on tracheal transplan-
tation?” I told him, “No idea.” He said, “Well, I just wanted to
avoid that we are still killing small or large animals.”
I congratulate you, first of all, because this is a very nice study.
However, I do have a few comments and some questions.
The comments are as follows. You are utilizing the same
principle that has been described by others in the 70s and 80s.
Since then, no one, except Eric Rose in 1971, has used the
principle by simply taking off a segment of trachea, placing it in
the muscles, sternocleidal muscle, and then implanting that oto-
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topically at 2 weeks. We don’t know if it worked, because there
was no publication following the first one. My problem is that all
the people who have already used clinically your support, which is
polytetrafluoroethylene, 100% of the time see emesis, bleeding,
infection, despite the use of indirect or direct revascularization.
And it makes sense if you try to generate tissue-engineered trachea
that is longer than 5 cm. But less than 5 cm, clinically, we do not
need that. This is from a clinical point of view.
The questions are the following: First, you used the mucosa, or
whatever, from the skin of the abdomen. From a methodological
point of view, would it be not better to simply take off the blood
samples and generate, as should be done in tissue engineering, this
respiratory epithelium simply from fibroblasts? This is the first
question.
Dr Kim. Actually this is 1 of a series of my experiments. At the
time, as already I told you, I used the buccal mucosa from the oral
cavity to make the mucosa line of the prosthesis. Originally the
buccal mucosa had that squamous epithelium; but after 6 months
of observation, the histology shows the epithelial cells change to
columnar epithelium just like the respiratory epithelial cells. So I
didn’t check the histology yet, but I’m just waiting. But I expect it
would be changed to the celiac columnar epithelium rather than
just the growth of the fibroblasts.
You said there are several groups that have used PTFE graft, or
mesh, but 1 of the most important things I think is the maintenance
of the viability of the prosthesis. At the time they just wrapped the
prosthesis with the omentum like that, because there was no
mucosa. That is why they had more infection and dehiscence, I
think.
Dr Macchiarini. The second question is, how are you sure that
these are really the epithelium that you have engrafted, simply
because if you transplant 5 cm of the trachea, you never know if
this . . . well, we should know from clinical and experimental data,
but still there is a migration from the proximal and lower stump
from the respiratory cells over the graft. So before you state that,
you should have made these biopsies, or at least a molecular
biologist study, to be sure that they are in place.
And concerning the variability of the graft, I think, looking at
the wonderful videos, just take care if you would like to transpose
that in clinical practice, because I didn’t see . . . for instance, the
muscle, the trachea muscle, the posterior wall is simply cartilage or
is whatever, just a circle. And if the patient or whatever needs to
breathe, then it will never work with the intrathoracic mechanics.
Dr Kim. That’s quite a good point. In my previous experi-
ments, you know, previously several Japanese groups reported that
there is some migration of the epithelial cells from the native
trachea, but the extent was less than 2 cm. Usually it’s just 1 cm
or less.
The reason why I used the 5-cm Rastelli replacement is to
watch whether there is the migration of the epithelial cells or just
a change of the epithelial cells. In my previous experiments, all the
epithelial cell layers, all the mucosal cells changed to respiratory
columnar epithelium, not just the anastomosis site. So yes, the
comment is quite good. Maybe I can use molecular biologist
techniques or something like that. But by histologic evaluation, I
think those cells are changing because of the respiratory environ-
ment.
Dr Douglas E. Wood (Seattle, Wash). I just wanted to make
sure I understood the sequence in your experimental model. This
model required 2 laparotomies, is that right? First, for harvesting
the epithelium and placing the prosthesis in the omentum, and then
a second laparotomy for transposition of the omentum and pros-
thesis up to the neck or chest.
Dr Kim. Yes. The first laparotomy is just harvesting of the
skin. But there are 2 laparotomies needed, the first just to put the
prosthesis in the omentum. And after a week, a week later, I use
the replacement of the prosthesis with fat by omental vessels to the
thoracic trachea.
Dr Wood. And have you noted any problem with mobility of
the omentum a week after it’s been manipulated and the prosthesis
placed in it?
Dr Kim. In my motion picture, you saw the wrap. The reason
why I used this is that after a week sometimes the omentum
adheres and sometimes there is some limitation of the mobiliza-
tion. That is why I wrapped in the first experiment in an abdominal
procedure.
Dr Wood. I guess I am wondering whether you think that one
might be able to skip a step and actually do it as a 1-stage operation
where the prosthesis, skin harvest, and omental wrapping is done
in situ at the same time as the tracheal replacement?
Dr Kim. I hope so, but I did not try it yet.
Dr Mark S. Allen (Rochester, Minn). Is there some problem
with making the initial graft a cylinder instead of a flat piece of
polypropylene? If you made it a cylinder initially, then you
wouldn’t have to fold it around and manipulate it.
Dr Kim. With the omentum, it’s really difficult to make a good
anastomosis when I do the thoracic tracheal replacement. That is
why I just open it and make a round tube when I do the thoracic
tracheal replacement.
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